Investor · San Diego, CA

David Kabakoff

Open David in the network graph →

Filings

60

SEC Form D

Connections

350

co-filers

Capital

$167.0M

across filings

Active

Sep 2012

to Nov 2021

Most-connected co-filers (350)

Tom Callaway · MENLO PARK, CA13 shared Richard Lin · MENLO PARK, CA11 shared Randy Scott · MENLO PARK, CA11 shared Thomas Jameson · Lexington, KY9 shared Garheng Kong · Menlo Park, CA9 shared Joseph J. Victor Jr · Seattle, WA7 shared William A. Hodges · Wilmington, DE6 shared Bryan Whang · Calabasas, CA6 shared Carolyn Fritz · San Diego, CA6 shared Michael Weintraub · Calabasas, CA6 shared Marc D. Oken · Charlotte, NC6 shared Andrew J. Schwab · Seattle, WA6 shared Simon Barnes · London, United Kingdom6 shared Thomas G. Dudeck · Hartford, CT5 shared Acertus Capital Management, Llc · Morristown, NJ5 shared Ronald Meeusen · Carmel, IN5 shared Donald F. Zibell · Northfield, MN5 shared George P. Waldeck · Newark, NJ5 shared Acertus Capital Management, Llc · Morristown, NJ5 shared James S. Tybur · Greenwich, CT4 shared Marcia W. Haydel · Greenwich, CT4 shared Jon W. Deklerk · Greenwich, CT4 shared Frank L. Brenninkmeyer · Greenwich, CT4 shared Taurus Ventures Capital Partners, LLC · Cary, NC4 shared

Recent filings (60)

NextCure, Inc.Dec 2025 · 23 co-filers$21.5M NextCure, Inc.Dec 2025 · 23 co-filers$21.5M RareCyte, Inc.Jul 2023 · 22 co-filers$35.7M Antiva Biosciences, Inc.Nov 2021 · 28 co-filers$31.0M Antiva Biosciences, Inc.Nov 2021 · 28 co-filers$31.0M RareCyte, Inc.Sep 2021 · 20 co-filers$24.0M Neurana Pharmaceuticals, Inc.Feb 2020 · 15 co-filers$64.9M Neurana Pharmaceuticals, Inc.Feb 2020 · 15 co-filers$64.9M Performance Venture Capital IV, L.P.Feb 2020 · 30 co-filers RareCyte, Inc.Dec 2019 · 16 co-filers$22.2M Performance EFFEM PE Fund, L.P.: Series 2020Dec 2019 · 37 co-filers Performance EFFEM PE Fund, L.P.: Series 2019Mar 2019 · 37 co-filers Rainier Therapeutics, Inc.Feb 2019 · 29 co-filers$20.0M NextCure, Inc.Nov 2018 · 19 co-filers$93.4M NextCure, Inc.Nov 2018 · 19 co-filers$93.4M Lorem Technologies Inc.Oct 2018 · 6 co-filers$2.5M Western Wealth Capital XXXIII US Investor, LPSep 2018 · 5 co-filers$10.0M Western Wealth Capital XXXIII US Investor, LPAug 2018 · 5 co-filers$10.0M Western Wealth Capital XXXIII US Investor, LPJun 2018 · 8 co-filers$10.0M Performance EFFEM PE Fund, L.P. - Series 2018Jun 2018 · 37 co-filers BioClin Therapeutics, Inc.May 2018 · 17 co-filers$50.0M Neurana Pharmaceuticals, Inc.May 2018 · 23 co-filers$3.8M Neurana Pharmaceuticals, Inc.May 2018 · 23 co-filers$64.9M BioClin Therapeutics, Inc.May 2018 · 17 co-filers$50.0M VERDELPHIS LPJun 2017 · 4 co-filers$1.5M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See David in the interactive graph →